Journal of the Japan Diabetes Society
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Search
Advanced search
OR
Browse
Search
Current issue
Displaying 1-9 of 9 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Feature
Diagnosis and Management of Hyperglycemic Disorders in Pregnancy
Original Article
Diagnosis, Treatment
  • Monitoring Changes in HbA1c in Patients With Diabetes Using a Smartphone-based Personal Health Record: A 24-month Analysis of the E-PROMIS Multicenter Cohort Study
    Osamu Tomonaga, Masahiro Fukuda, Harumi Iwasaki, Yasuhisa Abe, Syoichi ...
    2024 Volume 67 Issue 3 Pages 154-163
    Published: March 30, 2024
    Released on J-STAGE: March 30, 2024
    DOIhttps://doi.org/10.11213/tonyobyo.67.154
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    (Objectives) We investigated whether using a smartphone personal health record (PHR) application would improve HbA1c levels and body weight in patients with type 2 diabetes. (Methods) This multicenter cohort study was conducted in 20 medical clinics. We analyzed 118 patients (97 men and 21 women) with type 2 diabetes who were able to use the Welby Mykarte PHR application. We measured HbA1c levels and body weight when the patients started using the PHR application and then every 3 months for 24 months. Patients were stratified according to the frequency at which they used the application (<15 or ≥15 times per month). (Results) HbA1c values improved significantly from 7.2 % at baseline to 6.8 % at 24 months in all patients. The frequent user group demonstrated a greater improvement (from 7.1 % to 6.4 %) in comparison to the infrequent user group. Body weight also decreased. (Conclusion) These data suggest that better compliance with lifestyle modifications through 24 months of use of a PHR application may bring about therapeutic effects, including improved HbA1c.

    View full abstract
    Download PDF (496K)
Case Report
  • A Case of Type 2 Diabetes Mellitus With Hepatic Encephalopathy Without Liver Cirrhosis
    Anna Tamai, Yosuke Yakushiji, Masayuki Hosoi
    2024 Volume 67 Issue 3 Pages 164-171
    Published: March 30, 2024
    Released on J-STAGE: March 30, 2024
    DOIhttps://doi.org/10.11213/tonyobyo.67.164
    JOURNAL RESTRICTED ACCESS
    Show abstractHide abstract

    We present the case of a 69-year-old man with type 2 diabetes mellitus. He had a medical history of hereditary hemorrhagic telangiectasia. Four months after being aware of the carbohydrate restriction, he was admitted to our hospital because of hyperglycemia and impaired consciousness. After admission, the patient was diagnosed with hyperammonemia and a portacaval shunt. BCAA treatment was initiated to prevent loss of muscle mass. Laxatives and metformin were administered, and the poor absorption of antibiotics, kanamycin, hyperammonemia, and consciousness disturbance improved. The quantity and quality of protein intake and defecation control are common issues in both hepatic encephalopathy and diabetes. To improve the patient's prognosis, as in this case, it is useful to consider treatment from multiple perspectives.

    View full abstract
    Download PDF (660K)
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top